share_log
Reuters ·  May 8 07:03
Verve Therapeutics Inc - First Patient Dosed in Heart-2 Phase 1B Clinical Trial of Verve-102
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment